Scarica l'app Stockscreener
5.80
3.99%
0.28
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RCEL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.52
Aprire:
$5.63
Volume 24 ore:
193.54K
Relative Volume:
0.55
Capitalizzazione di mercato:
$152.79M
Reddito:
$50.14M
Utile/perdita netta:
$-35.38M
Rapporto P/E:
-4.1429
EPS:
-1.4
Flusso di cassa netto:
$-39.46M
1 W Prestazione:
+7.09%
1M Prestazione:
+0.70%
6M Prestazione:
-34.62%
1 anno Prestazione:
-40.27%
Intervallo 1D:
$5.63
$5.90
Intervallo di 1 settimana:
$3.60
$5.90
Portata 52W:
$3.60
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
Nome
Avita Medical Inc
Settore
Industria
Telefono
661-568-1317
Indirizzo
28159 AVENUE STANFORD, VALENCIA, CA
Confronta RCEL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
5.78 | 127.15M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
129.04 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.58 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
376.58 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.48 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-08 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-12-24 | Iniziato | D. Boral Capital | Buy |
| 2024-04-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-06-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-03-02 | Iniziato | Piper Sandler | Overweight |
| 2020-08-27 | Iniziato | BofA Securities | Buy |
| 2020-04-21 | Iniziato | Oppenheimer | Outperform |
| 2020-03-03 | Iniziato | BTIG Research | Buy |
Mostra tutto
Avita Medical Inc Borsa (RCEL) Ultime notizie
Avita Medical: Equity Raise Derisks Runway to Positive Cash Flow - Morningstar
Analysts Are More Bearish On AVITA Medical, Inc. (NASDAQ:RCEL) Than They Used To Be - Yahoo Finance
Institutional Tools Highlight Unusual Flow in AVITA Medical Inc.2025 Support & Resistance & Safe Capital Growth Tips - 선데이타임즈
Analysts Set Avita Medical Inc. (NASDAQ:RCEL) Price Target at $13.60 - MarketBeat
Avita Medical (NASDAQ:RCEL) Rating Lowered to "Sell" at BTIG Research - MarketBeat
Avita’s Road to Profitability Is in Sight - Morningstar
Avita Medical says it completed Australian equity raise - MarketScreener
Avita Medical (NASDAQ:RCEL) Lowered to Sell Rating by Wall Street Zen - MarketBeat
Avita Medical (NASDAQ:RCEL) Price Target Cut to $18.00 by Analysts at D. Boral Capital - MarketBeat
Lake Street Capital Issues Pessimistic Forecast for Avita Medical (NASDAQ:RCEL) Stock Price - MarketBeat
AVITA Medical Successfully Completes Australian Equity Raise | RCEL Stock News - GuruFocus
AVITA Medical Successfully Completes Australian Equity Raise - The Manila Times
AVITA Medical Raises US$15M from Australian Investors to Fuel Growth Until Cash Flow Positive - Stock Titan
Evernest Financial Advisors LLC Buys New Position in Avita Medical Inc. (NASDAQ:RCEL) - MarketBeat
Dr. Michael Tarnoff - DOTmed
Lake Street Capital Markets assumes coverage on Avita Medical stock with Buy rating - Investing.com Canada
Avita Medical shares rise 3.29% premarket after announcing an investor webinar briefing. - AInvest
Visualizing AVITA Medical Inc. stock with heatmapsShort-Term Swing Opportunity Summary Sheet - Newser
Avita Medical (NASDAQ:RCEL) Cut to Sell at BTIG Research - Defense World
What momentum shifts mean for AVITA Medical Inc.Real-Time Equity Price Action Analysis - Newser
Full technical analysis of AVITA Medical Inc. stockFree Investment Plan With Growth Optimization - Newser
AVITA Medical to Host Investor Webinar: Financial and Business Update - AInvest
AVITA Medical to Host Investor Webinar Briefing - The Manila Times
AVITA Medical CEO to Present Q2 Earnings Deep Dive: How to Join the Upcoming Investor Briefing - Stock Titan
AVITA Medical (RCEL.O) Suffers 21% Drop: A Technical and Order-Flow Deep Dive - AInvest
AVITA Medical, Inc. (NASDAQ:RCEL) Not Doing Enough For Some Investors As Its Shares Slump 25% - simplywall.st
Avita projects $76M–$81M 2025 revenue with rebound expected as claims backlog eases - MSN
Lower fair value for undervalued ASX share - Morningstar
Avita Medical Q2 2025 Revenue at $18.4M, Projects $76M-$81M 2025 Revenue with Backlog Easing - AInvest
AVITA Medical 2025 Q2 Earnings Narrowed Losses, Revenues Up but Guidance Cut - AInvest
Is AVITA Medical Inc. forming a bottoming baseBollinger Band Squeeze and Expansion Analysis - Newser
Orica Limited Updates on Share Buy-Back Progress - The Globe and Mail
Avita Medical shares rise 2.82% after-hours after revising earnings guidance for 2025. - AInvest
Avita Medical: Navigating Short-Term Reimbursement Headwinds, Unlocking Long-Term Growth in Acute Wound Care - AInvest
BTIG Downgrades Avita Medical(RCEL.US) to Sell Rating, Announces Target Price $3 - 富途牛牛
Form 424B5 AVITA Medical, Inc. - StreetInsider
BTIG Downgrades AVITA Medical to Sell From Neutral, Price Target is $3 - MarketScreener
Earnings call transcript: Avita Medical Q2 2025 reveals revenue miss, stock tumbles - Investing.com Canada
Avita Medical stock downgraded to Sell by BTIG on reimbursement issues - Investing.com Canada
AVITA Medical, Inc. SEC 10-Q Report - TradingView
Avita Medical shares fall 31.97% premarket after revising earnings guidance for 2025. - AInvest
Avita Medical Q2 2025 slides: revenue grows 21% but guidance slashed on reimbursement delays - Investing.com Canada
AVITA Medical Inc (AVHHL) Q2 2025 Earnings Call Highlights: Reve - GuruFocus
Avita Medical (RCEL) Q2 Sales Up 21% - AOL.com
Transcript : AVITA Medical, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
AVITA Medical Reports Q2 2025 Financial Results - TipRanks
Avita Medical (RCEL) Q2 Sales Up 21% - The Motley Fool
Guess which ASX All Ords stock just crashed 23% on earnings miss - The Motley Fool Australia
Published on: 2025-08-08 05:19:09 - beatles.ru
Avita Medical earnings missed by $0.13, revenue fell short of estimates - Investing.com Canada
Avita Medical Amends Credit Agreement with OrbiMed - TipRanks
Avita Medical Inc Azioni (RCEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Avita Medical Inc Azioni (RCEL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| McNamara Robert | Director |
Mar 06 '25 |
Buy |
8.30 |
11,000 |
91,300 |
56,749 |
| McNamara Robert | Director |
Feb 20 '25 |
Buy |
10.09 |
10,000 |
100,900 |
45,749 |
| O'Toole David D | CFO |
Feb 20 '25 |
Buy |
9.90 |
1,000 |
9,900 |
25,734 |
| O'Toole David D | CFO |
Feb 19 '25 |
Buy |
10.25 |
1,000 |
10,250 |
24,734 |
| Crowe Suzanne | Director |
Dec 09 '24 |
Buy |
13.15 |
486 |
6,391 |
36,912 |
| O'Toole David D | CFO |
Dec 05 '24 |
Buy |
12.46 |
975 |
12,152 |
23,734 |
0.59%
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):